当前位置: X-MOL 学术Fertil. Steril. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Intracytoplasmic sperm injection (ICSI) for non-male factor indications: a committee opinion.
Fertility and Sterility ( IF 6.6 ) Pub Date : 2020-07-09 , DOI: 10.1016/j.fertnstert.2020.05.032
1
Affiliation  

Intracytoplasmic sperm injection, while typically effective for overcoming low or absent fertilization in couples with a clear abnormality of semen parameters, is frequently used in combination with assisted reproductive technologies for other etiologies of infertility in the presence of semen parameters that meet the World Health Organization 2010 normative reference values. This committee opinion provides a critical review of the literature, where available, to identify situations where this may or may not be of benefit. This document replaces the previously published document of the same name, last published in 2012 (Fertil Steril 2012;98:1395–9).



中文翻译:

非男性因素适应症的胞浆内精子注射(ICSI):委员会意见。

胞浆内精子注射通常可有效克服夫妻精液参数明显异常的受精率低或缺乏的现象,但在存在符合世界卫生组织2010年标准的精液参数的情况下,通常与辅助生殖技术结合用于其他不孕病因规范性参考值。该委员会的意见对现有文献进行了严格的审查,以找出可能有益或可能不利的情况。本文档替代了之前发布的相同名称的文档,该文档的最后发行日期为2012年(Fertil Steril 2012; 98:1395–9)。

更新日期:2020-07-09
down
wechat
bug